Ronald Surowitz
Expertise in
1
conditions

Dr. Ronald Surowitz

Family Medicine
Mark T Agrama MD PA
500 University Blvd Ste 208, 
Jupiter, FL 
Offers Telehealth
Expertise in
1
conditions
Mark T Agrama MD PA
500 University Blvd Ste 208, 
Jupiter, FL 

Overview

Ronald Surowitz is a primary care provider, practicing in Family Medicine in Jupiter, Florida.

Dr. Surowitz is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lymphadenitis, Hypothyroidism, Obesity in Children, and Idiopathic Hypercalciuria.

He is actively involved in clinical research, co-authoring 2 peer reviewed articles and participating in 11 clinical trials.

Specialties

Family Medicine

Licenses

Family Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 2 Less Insurance Carriers -

Locations

Mark T Agrama MD PA
500 University Blvd Ste 208, Jupiter, FL 33458

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Evaluation of the ctDNA LUNAR Test in an Average Patient Screening Episode
Enrollment Status: Active_not_recruiting
Publish Date: May 14, 2026
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
A Phase 4, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Galcanezumab Versus Rimegepant in Adult Participants With Episodic Migraine
Enrollment Status: Completed
Publish Date: June 28, 2024
Intervention Type: Drug
Study Drugs: Galcanezumab, Rimegepant
Study Phase: Phase 4
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
A Phase 3, Multicenter, Randomized, Placebo-controlled, Double-blind, 22-Week and 30-Week Open-label Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of X0002 Spray in Relief of the Pain for Subjects With Osteoarthritis of the Knee
Enrollment Status: Completed
Publish Date: March 28, 2024
Intervention Type: Drug
Study Drug: X0002
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of STS101 (Dihydroergotamine Nasal Powder) in the Acute Treatment of Migraine
Enrollment Status: Completed
Publish Date: November 27, 2023
Intervention Type: Drug
Study Drug: Dihydroergotamine
Study Phase: Phase 3
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Blood Collection Sub-Study of Exact Sciences Protocol 2019-01: Clinical Validation of an Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, For Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 28, 2023
Intervention Type: Other
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening BLUE-C
Enrollment Status: Completed
Publish Date: September 01, 2023
Intervention Type: Procedure, Diagnostic test
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
A 12-Month, Randomized, Active-controlled, Open-label Study of the Efficacy and Safety of Oral Testosterone Undecanoate in Hypogonadal Men (RE-TUne)
Enrollment Status: Completed
Publish Date: June 28, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
A Randomized, Non-inferiority, Phase 3, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Abaloparatide-sMTS for the Treatment of Postmenopausal Women With Osteoporosis (the wearABLe Study)
Enrollment Status: Completed
Publish Date: February 15, 2023
Intervention Type: Combination product
Study Drugs: Abaloparatide solid microstructured transdermal system, Abaloparatide subcutaneous
Study Phase: Phase 3
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
AMPOWER A Single-arm, Phase III, Open Label, Multi-center, Study in Women Aged 18-35 Years of the Contraceptive Efficacy and Safety of Phexxi™ (Previously Referred to as AMPHORA®) Contraceptive Vaginal Gel
Enrollment Status: Completed
Publish Date: September 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
Enrollment Status: Completed
Publish Date: June 25, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 9 Less Clinical Trials

2 Total Publications

Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain.
Monoclonal antibodies against GFRα3 are efficacious against evoked hyperalgesic and allodynic responses in mouse join pain models but, one of these, REGN5069, was not effective against pain in a randomized, placebo-controlled clinical trial in patients with osteoarthritis pain.
Journal: Neurobiology of pain (Cambridge, Mass.)
Published: February 14, 2023
Similar Doctors
Expertise in
24
conditions
Dr. Richard Delucia
Family Medicine
Expertise in
24
conditions
Dr. Richard Delucia
Family Medicine

Jupiter Familyhealthcare PA

4600 Military Trl Ste 115, 
Jupiter, FL 
 (2.1 miles away)
561-776-5253
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Richard Delucia is a primary care provider, practicing in Family Medicine in Jupiter, Florida. Dr. Delucia is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Sitosterolemia, High Cholesterol, Hypertension, and Familial Hypertension.

Expertise in
19
conditions
Dr. Christopher Keller
Family Medicine
Expertise in
19
conditions
Dr. Christopher Keller
Family Medicine

Health And Wellness Center, Hobe Sound

11600 Southeast Federal Highway, 
Hobe Sound, FL 
 (9.8 miles away)
772-223-4943
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Christopher Keller is a primary care provider, practicing in Family Medicine in Hobe Sound, Florida. Dr. Keller is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and High Cholesterol. Dr. Keller is board certified in American Osteopathic Board Of Family Physicians, 2005.

Expertise in
11
conditions
Dr. Giovanni Spatola
Family Medicine
Expertise in
11
conditions
Dr. Giovanni Spatola
Family Medicine

Cleveland Clinic

4520 Donald Ross Rd Ste 200, 
Palm Beach Gardens, FL 
 (5.1 miles away)
561-904-7200
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Giovanni Spatola is a primary care provider, practicing in Family Medicine in Palm Beach Gardens, Florida. Dr. Spatola is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Vitamin D Deficiency, Vitamin B12 Deficiency Anemia, Multiple Carboxylase Deficiency, and Folate Deficiency.

Frequently Asked Questions about Dr. Ronald Surowitz

How do I make an appointment with Dr. Ronald Surowitz?

You can book an appointment with Dr. Ronald Surowitz by calling their office at 561-743-6297. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Ronald Surowitz a top-rated expert for Lymphadenitis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Ronald Surowitz is classified as an Advanced expert for Lymphadenitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Ronald Surowitz specialize in?

While Dr. Ronald Surowitz is a Family Medicine, they have specific expertise in Lymphadenitis, Hypothyroidism, and Obesity in Children. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Family Medicine.

Does Dr. Ronald Surowitz participate in research or clinical trials?

Yes. Dr. Ronald Surowitz has published 2 articles and abstracts on conditions like Lymphadenitis. You can view a list of Dr. Ronald Surowitz's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Ronald Surowitz accept my insurance?

Dr. Ronald Surowitz accepts most major insurance plans, including Blue Cross Blue Shield and Cigna. We recommend calling the office directly at 561-743-6297 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Surowitz's expertise for a condition
ConditionClose
      View All 34 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile